Averbum, MB - financials and debts

Company age: 3 y. 0 mo.

Update

Averbum - Company finances

EUR
2023
From: 2023-09-12
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 8,670 31,730 32,393
Profit before tax 7,822 -83 1,216
Net profit 7,822 -83 1,148
Equity 7,823 7,740 8,888
Liabilities 25,412 55,680 5,428
Non-current assets 0 28,014 24,124
Current assets 33,235 61,206 13,421
Total assets 33,235 89,220 37,545
Taxes paid
STI taxes 18 8,260 2,637
Financial indicators
Revenue change y/y - +266.0% +2.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 23.5% -0.1% 3.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 100.0% -1.1% 12.9%
Profit margin Net profit margin. Shows the overall profitability of the company. 90.2% -0.3% 3.5%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 90.2% -0.3% 3.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 3.2 7.2 0.6
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 8,670 14,644 14,950

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Averbum - Social security debts

From To Debt, €
2024-08-19 2024-09-03 0.01
2024-07-24 2024-08-05 0.01
2024-05-16 2024-05-16 9.71

Averbum - VMI tax arrears

From To Overdue, €
2025-09-05 2025-09-19 2.33
2025-09-02 2025-09-04 1.85
2025-07-04 2025-07-20 0.85
2025-07-03 2025-07-03 170.62

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Averbum, MB (code 306411901) is a Lithuanian small partnership engaged in research and development in natural sciences. In 2025, the latest financial year, the company generated revenue of €32.4K, up 2.1% year on year and 273.6% over two years, reflecting a clear expansion from €8.7K in 2023 and €31.7K in 2024. Net profit improved to €1.1K in 2025 after a slight loss of €83 in 2024, following profit of €7.8K in the shorter 2023 period. The 2025 profit margin was 3.5%, compared with -0.3% in 2024 and 90.2% in 2023, which covered only 110 days. At year-end 2025, total assets stood at €37.5K, equity at €8.9K and liabilities at €5.4K. The balance sheet structure improved materially versus 2024, when liabilities were much higher and assets reached €89.2K. Key ratios for 2025 show ROE of 12.9%, ROA of 3.1%, debt-to-equity of 0.61 and asset turnover of 0.86x. Revenue per employee was €16.2K, with profit per employee of €574.